Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BL-15
- Development stage
- Preclinical
- Lead developer
- BioLeonhardt
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Administration
- Implant
01
Overview
BL-15 is a proprietary 15-component regenerative composition developed by BioLeonhardt for heart regeneration. It is designed to be delivered via a micro-infusion pump as part of a multi-modal platform that combines bioelectric stimulation with biological factors. The composition is intended to promote stem cell homing, angiogenesis, and myocardial repair in patients with heart failure and other cardiovascular conditions. The cocktail typically includes a mixture of growth factors, proteins, and signaling molecules such as SDF-1, VEGF, HGF, and IGF-1, which work synergistically to recruit endogenous stem cells and support the regeneration of damaged heart tissue.
- Other names
- BL-15 CompositionBL15 CompositionBL 15 CompositionBioLeonhardt 15BioLeonhardt15BioLeonhardt-15
02
Targets
CXCR7 (CXC chemokine receptor 7)VEGFR2 (Vascular endothelial growth factor receptor 2)MET (Mesenchymal-epithelial transition factor receptor)NOS3 (eNOS)CXCR4 (C-X-C motif chemokine receptor 4)PDGFR (PDGFR family)CSF3R (Granulocyte colony-stimulating factor receptor)FGFR (Fibroblast growth factor receptor)IGF-1R (Insulin-like growth factor 1 receptor)
Beyond the preview
Go deeper on BL-15.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BL-15.